OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
Increasing molecular diversity is creating a need for the reinvention of process development and control strategies.
A thorough knowledge of both the upstream and downstream processes is required to ensure effective removal of residual impurities in biopharmaceuticals.
Pharma companies set goals and adopt more sustainable alternatives.
Learning from early market failures, the biopharma industry has worked to improve the fate of antibody drug conjugates.
Experts reveal how to identify the “right” biochemical, the process of sourcing biochemicals, sourcing challenges, and what industry professionals should know about the space.
Industry experts discuss best practices for certificates of analysis.
Various advances in contamination control are being utilized to reduce the chance pollutants contaminate a drug product.
November 09, 2022
The UK MHRA has expanded the use of Cosentyx for use in pediatric arthritic conditions.
November 08, 2022
The collaboration will see Shimadzu and UMG develop new clinical laboratory methods using LC-MS for TDM analysis.
MGI and Imperial College will jointly operate a CEC designed to provide European customers with first-hand experience with various automation and sequencing instruments.
Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.
Companies need to consider and address formulation challenges to employ a successful reformulation strategy.
An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.
November 02, 2022
Gerresheimer and Nelson Labs will work together to conduct extractables and leachables testing on upcoming primary packaging solutions.
Under this deal, Merck, known as MSD outside of the United States and Canada, will select Veeva products for industry-specific software and data.
Johnson & Johnson’s acquisition of Abiomed, a provider of heart pump technologies, is designed to bolster their position in the medical technology sector.
Steriline will be exhibiting its vial filling and capping machine (VFCM100) under double-wall isolator for aseptic filling at CPHI 2022 in Frankfurt, Germany, on Nov. 1–3, 2022.
New medications show exciting outcomes for weight loss.
Lonza and Singzyme will use Singzyme’s enzymatic conjugation platform to develop novel bioconjugates.